Published in Clin Endocrinol (Oxf) on January 01, 1999
Diagnosis and management of Graves' disease. CMAJ (2003) 1.20
Current and emerging treatment options for Graves' hyperthyroidism. Ther Clin Risk Manag (2010) 1.07
Current concepts in graves' disease. Ther Adv Endocrinol Metab (2011) 0.91
Medical management of thyroid eye disease. Saudi J Ophthalmol (2010) 0.87
Pediatric Graves' disease: management in the post-propylthiouracil Era. Int J Pediatr Endocrinol (2014) 0.85
Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016. Clin Pediatr Endocrinol (2017) 0.79
Antithyroid drugs in Graves' disease: Are we stretching it too far? Indian J Endocrinol Metab (2016) 0.75
Indefinite antithyroid drug therapy in toxic Graves' disease: What are the cons. Indian J Endocrinol Metab (2013) 0.75
Comparison of methimazole/hydrocortisone ointment with oral methimazole in patients with graves disease: A prospective, randomized, open-label, parallel-group, 18-month study. Curr Ther Res Clin Exp (2008) 0.75
Predicting relapse of Graves' disease following treatment with antithyroid drugs. Exp Ther Med (2016) 0.75
Impaired leucocyte functions in diabetic patients. Diabet Med (1997) 3.33
Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int (2006) 2.52
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine. Clin Endocrinol (Oxf) (1998) 1.99
Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations. Muscle Nerve (2004) 1.73
A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1985) 1.69
Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism? Neurology (2007) 1.59
Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT scans. Eur J Nucl Med Mol Imaging (2006) 1.53
Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc Natl Acad Sci U S A (1984) 1.52
Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci U S A (1996) 1.47
The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancer. Ann Surg Oncol (2005) 1.45
Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients. Diabetes Care (1994) 1.38
Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta (1993) 1.21
Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab (1990) 1.20
Gallium-67 in the evaluation of sarcoidosis: correlations with serum angiotensin-converting enzyme and bronchoalveolar lavage. Thorax (1982) 1.17
Anion selectivity by the sodium iodide symporter. Endocrinology (2003) 1.16
Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly. Clin Endocrinol (Oxf) (2000) 1.15
Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. Radiology (1988) 1.08
Long-term culture of human pancreatic islets in an extracellular matrix: morphological and metabolic effects. Mol Cell Endocrinol (1993) 1.07
Long-term complications of total body irradiation in adults. Int J Radiat Oncol Biol Phys (2001) 1.05
Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat. Lab Anim (2005) 1.04
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas. Clin Cancer Res (1998) 1.04
Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology (1988) 1.04
Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007. Diabetologia (2009) 1.03
HLA and Graves' disease: an association with HLA-DRw3. J Clin Endocrinol Metab (1980) 1.02
Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab (2011) 1.02
Systemic vasculitis in patients with hepatitis C. J Rheumatol (2001) 0.99
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience. Leukemia (2011) 0.99
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer. Br J Cancer (2009) 0.97
G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis. Br J Cancer (2004) 0.96
Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas. Br J Cancer (2008) 0.95
Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis. Arthritis Rheum (2000) 0.95
Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol (1996) 0.93
Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines. Eur J Endocrinol (2011) 0.93
Randomized clinical trial comparing axillary padding with closed suction drainage for the axillary wound after lymphadenectomy for breast cancer. Br J Surg (2006) 0.93
Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for inherited neurological disorders. Hum Mol Genet (1996) 0.92
Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement. Eur J Nucl Med (2000) 0.90
Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis. Immunogenetics (1985) 0.90
Clinical and statistical evaluation of self-monitoring blood glucose meters. Diabetes Care (1998) 0.90
Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur J Surg Oncol (2003) 0.89
Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Clin Endocrinol (Oxf) (2001) 0.89
Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. Eur Rev Med Pharmacol Sci (2014) 0.89
Pubic pain syndrome in sportsmen: comparison of radiographic and scintigraphic findings. Eur J Nucl Med (1984) 0.88
Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier. Int J Cancer (2001) 0.88
Pheochromocytoma and secondary erythrocytosis: role of tumour erythropoietin secretion. Nouv Rev Fr Hematol (1995) 0.87
[Diagnosis of flat epithelial atypia (FEA) after stereotactic vacuum-assisted biopsy (VAB) of the breast: What is the best management: systematic surgery for all or follow-up?]. J Radiol (2006) 0.85
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease? Clin Endocrinol (Oxf) (1984) 0.85
Properdin factor B (Bf) and glyoxalase in Graves' disease. Acta Endocrinol (Copenh) (1983) 0.83
Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus. Metabolism (1996) 0.83
Prognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 cases. Eur J Surg Oncol (2011) 0.82
Sphingolipid-cholesterol domains (lipid rafts) in normal human and dog thyroid follicular cells are not involved in thyrotropin receptor signaling. Endocrinology (2003) 0.82
[Cryptococcal meningitis associated with chronic lymphocytic leukemia: a case report. Review of the literature]. Rev Med Interne (2000) 0.82
Serum lysosomal acid hydrolase activities in Graves' disease. Clin Chim Acta (1982) 0.82
Anti-pancreatic autoimmunity and Graves' disease: study of a cohort of 600 Caucasian patients. Eur J Endocrinol (1997) 0.82
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections. Clin Cancer Res (1999) 0.82
Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs. Eur J Nucl Med Mol Imaging (2003) 0.82
Kinetics of thyrotropin-stimulating hormone (TSH) and thyroid-stimulating antibody binding and action on the TSH receptor in intact TSH receptor-expressing CHO cells. J Clin Endocrinol Metab (2003) 0.82
Post-operative care and patient satisfaction after ambulatory surgery for breast cancer patients. Eur J Surg Oncol (2005) 0.81
AL amyloidosis combined with acquired factor V deficiency. Ann Intern Med (1998) 0.81
In Chinese hamster ovary K1 cells dog and human thyrotropin receptors activate both the cyclic AMP and the phosphatidylinositol 4,5-bisphosphate cascades in the presence of thyrotropin and the cyclic AMP cascade in its absence. Eur J Biochem (1995) 0.81
[Significance of 99mTc-diethyl-IDA scintigraphy in the diagnosis of biliary duct atresia]. Ann Pediatr (Paris) (1983) 0.80
[Primary adrenal lymphoma with latent adrenal insufficiency: a case report and literature review]. Ann Endocrinol (Paris) (1998) 0.80
Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease. Clin Chem (1986) 0.80
[Central nervous system involvement in hepatitis C virus infection]. Gastroenterol Clin Biol (1999) 0.80
Species specific thyroid signal transduction: conserved physiology, divergent mechanisms. Mol Cell Endocrinol (2010) 0.80
Biological and hemodynamic effects of low doses of fludrocortisone and hydrocortisone, alone or in combination, in healthy volunteers with hypoaldosteronism. Clin Pharmacol Ther (2010) 0.80
Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures. Mol Cell Endocrinol (2006) 0.80
Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft. J Nucl Med (1999) 0.79
Gallium-67 imaging in muscular sarcoidosis. J Nucl Med (1984) 0.79
GH deficiency in adults: an epidemiological approach. Eur J Endocrinol (1999) 0.79
Scintigraphic assessment of indium-111-labeled granulocyte splenic pooling: a new approach to inflammatory bowel disease activity. J Nucl Med (1990) 0.79
Identification of a novel mutation (A268G) in exon 8 of the HTR beta gene in a large family with thyroid hormone resistance. Hum Mutat (1996) 0.79
The orphan receptor cDNA RDC4 encodes a 5-HT1D serotonin receptor. Biochem Biophys Res Commun (1991) 0.79
Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 0.79
[Synthetic antithyroid drugs and Basedow's disease or the choice of a therapeutic strategy]. Presse Med (1991) 0.79
[Laparoscopic sentinel lymph node (SLN) dissection for clinically localized prostate carcinoma: results obtained in the first 70 patients]. Prog Urol (2011) 0.79
Pure tubular carcinoma of the breast and sentinel lymph node biopsy: a retrospective multi-institutional study of 234 cases. Eur J Surg Oncol (2012) 0.78
The human and dog 5-HT1D receptors can both activate and inhibit adenylate cyclase in transfected cells. Eur J Pharmacol (1993) 0.78
[Detection of thyrostimulating immunoglobulins in whole serum. Value of the culture of human thyroid cells]. Presse Med (1983) 0.78
[Helical tomotherapy in the treatment of malignant pleural mesothelioma: The impact of low doses on pulmonary and oesophageal toxicity]. Cancer Radiother (2013) 0.78
[Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas]. J Gynecol Obstet Biol Reprod (Paris) (2003) 0.78
Indium 111 autologous granulocytes in the diagnosis of abscess and in the assessment of inflammatory bowel disease. Int J Rad Appl Instrum B (1986) 0.77
Factor B (Bf) and glyoxalase genes in insulin-dependent diabetes mellitus. Diabete Metab (1985) 0.77
Use of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients without detectable iodine uptake. Eur J Nucl Med (1998) 0.77
Comparative effects of 6 week fructose, dextrose and starch feeding on fat-cell lipolysis in normal rats: effects of isoproterenol, theophylline and insulin. Mol Cell Biochem (1992) 0.77
[Lipiodolized angiography in hepatocellular carcinomas. Contribution of iodine-131-labelled lipiodol]. J Radiol (1986) 0.77
A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype. J Clin Endocrinol Metab (1983) 0.77
[Anti-TPO antibodies and screening of thyroid dysfunction in type 1 diabetic patients]. Ann Endocrinol (Paris) (2000) 0.77